VeriMomHamilelikte cannabinol kullanmaktan kaçınmalı mıyım? | VeriMom
Cannabinol (CBN, CAS 521-35-7) has limited direct human pregnancy data but is a phytocannabinoid acting on the endocannabinoid system; preclinical data report reproductive effects after maternal cannabinoid exposures (including a rodent report implicating maternal exposure to CBN/CBD with reduced sperm in male offspring), and many supplier SDSs/self-classifications list Repr. 2 (H361) as a suspected reproductive hazard. There is no clear harmonised CLP (Annex VI) listing for CBN, so the concern is scored as 'suspected' rather than 'confirmed'. Sources: PubChem summary, peer-reviewed reviews on cannabinoids in pregnancy, and supplier SDSs showing H361 self-classification.
ECHA regulatory hazard statements
- •H361
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabinol hamilelikte güvenli mi?
- Cannabinol (CBN, CAS 521-35-7) has limited direct human pregnancy data but is a phytocannabinoid acting on the endocannabinoid system; preclinical data report reproductive effects after maternal cannabinoid exposures (including a rodent report implicating maternal exposure to CBN/CBD with reduced sperm in male offspring), and many supplier SDSs/self-classifications list Repr. 2 (H361) as a suspected reproductive hazard. There is no clear harmonised CLP (Annex VI) listing for CBN, so the concern is scored as 'suspected' rather than 'confirmed'. Sources: PubChem summary, peer-reviewed reviews on cannabinoids in pregnancy, and supplier SDSs showing H361 self-classification.
- cannabinol emzirirken güvenli mi?
- Cannabinoids as a class (notably THC) are known to concentrate in breast milk with potential neonatal exposures; specific CBN breastfeeding data are sparse, but by analogy to other phytocannabinoids and because CBN is lipophilic and can be systemically absorbed, a suspected reproductive/neonatal hazard is prudent (scored H=2). Mechanistic concern is class-based (endocannabinoid receptor activity). Measured dermal/topical systemic transfer data for CBN in nursing people are lacking, so exposure from cosmetic topical use is considered low but measurable.
- cannabinol bebek cildi için güvenli mi?
- Infant skin has higher surface-area-to-weight and an immature barrier. For CBN the hazard and mechanism scores follow adult values (suspected reproductive hazard via ECS-related effects), and exposure is increased by +1 for 0–3 yr skin because CBN is lipophilic and topical absorption is plausible and measurable; specific infant dermal absorption data for CBN are lacking.
- VeriMom cannabinol nasıl puanlıyor?
- VeriMom cannabinol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte cannabinol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.